Acute kidney injury (AKI) is estimated to occur in up to 50% of patients with liver cirrhosis and is associated with increased morbidity and a high risk of short-term and long-term mortality.1 ...

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic dysfunction-associated steatotic liver disease (MASLD), a chronic liver condition that ...